Aspartame-induced  	Aspartame-induced  	 JJ	O
fibromyalgia 	fibromyalgia 	 NN	B-NP
,  	,  	 ,	O
an  	an  	 DT	O
unusual  	unusual  	 JJ	O
but  	but  	 CC	O
curable  	curable  	 JJ	O
cause  	cause  	 NN	O
of  	of  	 IN	O
chronic  	chronic  	 JJ	B-NP
pain  	pain  	 NN	I-NP
We  	We  	 PRP	O
report  	report  	 VBP	O
for  	for  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
time  	time  	 NN	O
an  	an  	 DT	O
unusual  	unusual  	 JJ	O
musculoskeletal  	musculoskeletal  	 JJ	O
adverse  	adverse  	 JJ	O
effect  	effect  	 NN	O
of  	of  	 IN	O
aspartame  	aspartame  	 NN	O
in  	in  	 IN	O
two  	two  	 CD	O
patients 	patients 	 NNS	O
.  	.  	 .	O
A  	A  	 DT	O
50-year-old  	50-year-old  	 JJ	O
woman  	woman  	 NN	O
had  	had  	 VBD	O
been  	been  	 VBN	O
suffering  	suffering  	 VBG	O
from  	from  	 IN	O
widespread  	widespread  	 JJ	O
pain  	pain  	 NN	O
and  	and  	 CC	O
fatigue  	fatigue  	 NN	O
for  	for  	 IN	O
more  	more  	 JJR	O
than  	than  	 IN	O
10  	10  	 CD	O
years  	years  	 NNS	O
leading  	leading  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
diagnosis  	diagnosis  	 NN	O
of  	of  	 IN	O
fibromyalgia 	fibromyalgia 	 NN	B-NP
.  	.  	 .	O
During  	During  	 IN	O
a  	a  	 DT	O
vacation  	vacation  	 NN	O
in  	in  	 IN	O
a  	a  	 DT	O
foreign  	foreign  	 JJ	O
country 	country 	 NN	O
,  	,  	 ,	O
she  	she  	 PRP	O
did  	did  	 VBD	O
not  	not  	 RB	O
suffer  	suffer  	 VB	O
from  	from  	 IN	O
painful  	painful  	 JJ	O
symptoms  	symptoms  	 NNS	B-NP
since  	since  	 IN	O
she  	she  	 PRP	O
had  	had  	 VBD	O
forgotten  	forgotten  	 VBN	O
to  	to  	 TO	O
take  	take  	 VB	O
her  	her  	 PRP$	O
aspartame 	aspartame 	 NN	O
.  	.  	 .	O
All  	All  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
symptoms  	symptoms  	 JJ	B-NP
reappeared  	reappeared  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
days  	days  	 NNS	O
following  	following  	 VBG	O
her  	her  	 PRP$	O
return  	return  	 NN	O
when  	when  	 WRB	O
she  	she  	 PRP	O
reintroduced  	reintroduced  	 VBP	O
aspartame  	aspartame  	 VBN	O
into  	into  	 IN	O
her  	her  	 PRP$	O
daily  	daily  	 JJ	O
diet 	diet 	 NN	O
.  	.  	 .	O
Thus 	Thus 	 RB	O
,  	,  	 ,	O
aspartame  	aspartame  	 NN	O
was  	was  	 VBD	O
definitively  	definitively  	 RB	O
excluded  	excluded  	 VBN	O
from  	from  	 IN	O
her  	her  	 PRP$	O
diet 	diet 	 NN	O
,  	,  	 ,	O
resulting  	resulting  	 VBG	O
in  	in  	 IN	O
a  	a  	 DT	O
complete  	complete  	 JJ	O
regression  	regression  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
fibromyalgia  	fibromyalgia  	 JJ	B-NP
symptoms 	symptoms 	 NNS	I-NP
.  	.  	 .	O
A  	A  	 DT	O
43-year-old  	43-year-old  	 JJ	O
man  	man  	 NN	O
consulted  	consulted  	 VBN	O
for  	for  	 IN	O
a  	a  	 DT	O
3-year  	3-year  	 JJ	O
history  	history  	 NN	O
of  	of  	 IN	O
bilateral  	bilateral  	 JJ	B-NP
forearm 	forearm 	 NN	I-NP
,  	,  	 ,	O
wrist 	wrist 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
hand  	hand  	 NN	O
and  	and  	 CC	O
cervical  	cervical  	 JJ	B-NP
pain  	pain  	 NN	I-NP
with  	with  	 IN	O
various  	various  	 JJ	O
unsuccessful  	unsuccessful  	 JJ	O
treatments 	treatments 	 NNS	O
.  	.  	 .	O
A  	A  	 DT	O
detailed  	detailed  	 JJ	O
questioning  	questioning  	 VBG	O
allowed  	allowed  	 VBN	O
to  	to  	 TO	O
find  	find  	 VB	O
out  	out  	 RP	O
that  	that  	 IN	O
he  	he  	 PRP	O
had  	had  	 VBD	O
been  	been  	 VBN	O
taking  	taking  	 VBG	O
aspartame  	aspartame  	 NN	O
for  	for  	 IN	O
three  	three  	 CD	O
years 	years 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
removal  	removal  	 NN	O
of  	of  	 IN	O
aspartame  	aspartame  	 NN	O
was  	was  	 VBD	O
followed  	followed  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
complete  	complete  	 JJ	O
regression  	regression  	 NN	O
of  	of  	 IN	O
pain 	pain 	 NN	O
,  	,  	 ,	O
without  	without  	 IN	O
recurrence 	recurrence 	 NN	O
.  	.  	 .	O
We  	We  	 PRP	O
believe  	believe  	 VBP	O
that  	that  	 IN	O
these  	these  	 DT	O
patients 	patients 	 NNS	O
'  	'  	 POS	O
chronic  	chronic  	 JJ	B-NP
pain  	pain  	 NN	I-NP
was  	was  	 VBD	O
due  	due  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
ingestion  	ingestion  	 NN	B-NP
of  	of  	 IN	O
aspartame 	aspartame 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
potent  	potent  	 JJ	O
flavouring  	flavouring  	 JJ	O
agent 	agent 	 NN	B-NP
,  	,  	 ,	O
widely  	widely  	 RB	O
used  	used  	 VBN	O
in  	in  	 IN	O
food  	food  	 NN	O
as  	as  	 IN	O
a  	a  	 DT	O
calorie-saver 	calorie-saver 	 JJ	B-NP
.  	.  	 .	O
The  	The  	 DT	O
benefit 	benefit 	 NN	O
/  	/  	 CD	O
risk  	risk  	 NN	B-NP
ratio  	ratio  	 NN	I-NP
of  	of  	 IN	O
considering  	considering  	 VBG	O
the  	the  	 DT	O
diagnosis  	diagnosis  	 NN	O
of  	of  	 IN	O
aspartame-induced  	aspartame-induced  	 JJ	O
chronic  	chronic  	 JJ	B-NP
pain  	pain  	 NN	I-NP
is  	is  	 VBZ	O
obvious 	obvious 	 JJ	O
:  	:  	 :	O
the  	the  	 DT	O
potential  	potential  	 JJ	B-NP
benefit  	benefit  	 NN	I-NP
is  	is  	 VBZ	O
to  	to  	 TO	O
cure  	cure  	 VB	O
a  	a  	 DT	O
disabling  	disabling  	 JJ	O
chronic  	chronic  	 JJ	B-NP
disease 	disease 	 NN	I-NP
,  	,  	 ,	O
to  	to  	 TO	O
spare  	spare  	 VB	O
numerous  	numerous  	 JJ	B-NP
laboratory  	laboratory  	 NN	I-NP
and  	and  	 CC	O
imaging  	imaging  	 JJ	O
investigations 	investigations 	 NNS	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
to  	to  	 TO	O
avoid  	avoid  	 VB	O
potentially  	potentially  	 RB	O
harmful  	harmful  	 JJ	O
therapies 	therapies 	 NNS	O
;  	;  	 :	O
the  	the  	 DT	O
potential  	potential  	 JJ	B-NP
risk  	risk  	 NN	I-NP
is  	is  	 VBZ	O
to  	to  	 TO	O
temporarily  	temporarily  	 RB	O
change  	change  	 VB	O
the  	the  	 DT	O
patient 	patient 	 NN	O
's  	's  	 POS	O
diet 	diet 	 NN	O
.  	.  	 .	O
Thus 	Thus 	 RB	O
,  	,  	 ,	O
practitioners  	practitioners  	 NNS	B-NP
should  	should  	 MD	O
ask  	ask  	 VB	O
patients  	patients  	 NNS	O
suffering  	suffering  	 VBG	O
from  	from  	 IN	O
fibromyalgia  	fibromyalgia  	 NN	B-NP
about  	about  	 IN	O
their  	their  	 PRP$	O
intake  	intake  	 NN	O
of  	of  	 IN	O
aspartame 	aspartame 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
some  	some  	 DT	O
cases 	cases 	 NNS	O
,  	,  	 ,	O
this  	this  	 DT	O
simple  	simple  	 JJ	O
question  	question  	 NN	O
might  	might  	 MD	O
lead  	lead  	 VB	O
to  	to  	 TO	O
the  	the  	 DT	O
resolution  	resolution  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
disabling  	disabling  	 JJ	O
chronic  	chronic  	 JJ	B-NP
disease 	disease 	 NN	I-NP
.  	.  	 .	O
